India to Papua New Guinea: Flucloxacillin Export Trade Route

The India to Papua New Guinea Flucloxacillin corridor is one of India's established pharmaceutical export routes, with 146 shipments documented worth a combined $1.4M USD. The route is dominated by MERIT ORGANICS LIMITED, which alone accounts for roughly 41% of all export value, reflecting the consolidated nature of India's flucloxacillin manufacturing sector.

Across 33 active suppliers, the average shipment value stands at $9.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with flucloxacillin's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 12.2%, placing it at rank #8 among India's top flucloxacillin export destinations globally.

On the import side, key buyers of Indian flucloxacillin in Papua New Guinea include NA, CITY PHARMACY LIMITEDP O BOX, TO THE ORDER and 39 others. NA is the single largest importer with 24 shipments valued at $694.7K USD.

India's flucloxacillin exports to Papua New Guinea are driven primarily by a handful of large-scale manufacturers. MERIT ORGANICS LIMITED with 16 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 33 active exporters signals a competitive but concentrated market — buyers in Papua New Guinea benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MERIT ORGANICS LIMITED, MERIT ORGANICS LIMITED , KOPRAN LIMITED — together account for 62% of total trade value on this route. The average shipment value of $9.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pharamaceutical formulations for human use: flucloxacillin capsule bp 250mg each hard gelatin capsule contai and flucloxacillin capsule bp 250 mg each hard gelatin capsule contains flucloxacillin sodium bp eq. to flucloxacillin 250mg, suggesting that buyers in Papua New Guinea tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, NA is the largest importer with 24 shipments worth $694.7K USD — representing 48% of all flucloxacillin imports from India on this route. A total of 42 buyers are active on this corridor.